Malith Karunasiri

Malith Karunasiri's research focuses on blood cancers, particularly acute myeloid leukemia (AML) and chronic myeloid leukemia, examining molecular mechanisms such as gene regulation, RNA molecules that control gene expression, and proteins involved in cell growth and cancer progression. Work also extends to complications of bone marrow transplantation, such as graft-versus-host disease, and to identifying potential drug targets like BRD4 and EGFL7. This research relies heavily on laboratory and mouse-model studies to understand leukemia biology and improve transplant outcomes.

Publication output has fluctuated over the past decade but shows a generally steady-to-growing pattern, with a notable increase in output from 2023 onward.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026